Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Study Phase
Phase 3
Study Completion Date
March 2012
NCT00678535Uploaded 04-17-2015
Available for Download
PDS UID: Gastric_MerckKG_2008_130
Open-label, Randomized, Controlled, Multicenter Phase III Study Investigating Cetuximab in Combination With Capecitabine (Xeloda, X) and Cisplatin (P) Versus XP Alone as First-line Treatment for Subjects With Advanced Gastric Adenocarcinoma Including Adenocarcinoma of the Gastroesophageal Junction
PDS UID: Gastric_Multipl_2008_415Go to Study
Enhancing the Analytic Capacity of Gastric_MerckKG_2008_130 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
PROTOCOLEMR 200048-052_EXPAND_Redacted Clinical Study Protocol.pdf
CRFEMR200048-052_Expand_SAS annotated eCRF_.pdf
DATA DICTIONARYData Dictionary.pdf
DATA (COMPARATOR ARM)EMR200048-052_Expand_Raw Data control